|Articles|May 16, 2011
Third agents for type 2 diabetes are similar in efficacy
NEW YORK (Reuters Health) - For patients with type 2 diabetes not controlled with metformin and a sulfonylurea, the choice of an additional agent should be based on individual clinical characteristics since improvements in glucose control are similar.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
COVID-19 Infection During First Trimester Increases Risk of Neonatal Risks
2
Older Adults Lack Understanding of OTC Drugs Despite Common Use
3
Maximizing Efficiency and Expansion of Vaccine Offerings in Pharmacy
4
Half of Patients Have Used Online Pharmacies But Under 10% Identified Safe Sites
5








































































































































